Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Probing Device Measures Potential Donors' Liver Function

By HospiMedica International staff writers
Posted on 10 Jun 2015
A portable finger-probe device can successfully measure liver function in brain-dead organ donors, according to a new study.

Researchers at the University of California Los Angeles (UCLA; USA) conducted a prospective study involving 53 consecutive adult, brain-dead donors to evaluate the finger-probe-based device as a rapid, noninvasive, measure of liver function performed before graft procurement. More...
The device operates much like a pulse oximeter, gauging liver function by indocyanine green plasma disappearance rates (ICG-PDR), after the dye is injected into the potential donor's bloodstream. The results were compared with graft function and outcomes. Both donor and recipient teams were blinded to ICG-PDR measurements.

The results showed that 11 liver grafts were declined by all centers because of quality; the other 42 grafts were transplanted. Logistic regression analysis showed that ICG-PDR results were the only donor variable to be significantly associated with seven-day graft survival. Other measures, including donor risk index, donor age, and transaminase levels at peak or procurement were not significantly associated with graft survival. The study was published early online on April 6, 2015, in the Journal of Surgical Research.

“This device is best single predictor of organ survival in our patients. Ultimately, what it does is gives us a quantitative measure of how good a liver is without having to visually inspect the organ,” said lead author Ali Zarrinpar, MD, an assistant professor of surgery in the division of liver and pancreas transplantation. “It gives us a measurement to talk about when we're thinking about whether to transplant an organ into a recipient.”

“These data warrant further exploration in a larger trial in a variety of settings to evaluate acceptable values for donated livers,” concluded Dr. Zarrinparand colleagues. “At a time of increasing regional sharing and calls for national organ sharing, this method would assist in the standardization of graft evaluation. It could also lead to increasing liver graft utilization while decreasing travel risk and expenses.”

About 17,000 adults and children approved for transplants are waiting for donated livers to become available every year in the US alone, with 1,500 people dying while waiting for one to become available. A liver transplant may involve the whole liver, a reduced liver, or a liver segment. Most transplants involve the whole organ, but segment transplants have been performed with increasing frequency in recent years. This would allow two liver recipients to be transplanted from one donor, or allow for living donor liver donation.

For the study, the researchers used the Pulsion Medical Systems (Feldkirchen, Germany) PulsioFlex device with LiMON Liver function technology.

Related Links:

University of California Los Angeles
Pulsion Medical Systems 



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.